It is my great pleasure to invite you to attend the 12th Jenner Glycobiology and Medicine Symposium “Translational Glycobiology – From Bench to Bedside” that will take place in Dubrovnik, Croatia on May 6-9, 2017.
The Jenner glycobiology and medicine symposia were the first and main international multidisciplinary conferences set up to examine the relevance of glycobiology to immunology, medicine and clinical practice. The symposia, since 2001, have been organised by the Royal Society of Medicine with the aim to widen clinical participation and to actively promote and foster greater interaction and collaboration between glycobiologists and clinicians.
With glyco-diagnostics and glyco-stratification of patients becoming reality and glycoengineered drugs entering the market, this series of conferences is more attractive than ever. In the last few years over 40,000 individual glycomes have been published. The interest among clinicians is increasing steadily and new evidence about the importance of glycans in diseases and disease models is being generated on regular basis . Methods for sample preparation, high-resolution analysis and quantification of glycans and glycopeptides are constantly being improved, promising further advances in our understanding of the role of protein glycosylation in disease.
Glycome integrates our genetic background with past and present environmental factors, thus it offers a promise of more efficient patient stratification than genetic polymorphisms (that are set for a lifetime of an individual). Until recently, this was only an elusive promise, but newly generated data are converting this promise into a reality. The progress is still slow, but considering the complexity of the glycome and the limited number of laboratories that can perform high-throughput glycomic studies, this is not surprising. However, the technology is now available and the interest for glycomics among researchers performing clinical and epigenetic studies is increasing steadily, thus further progress leading to new and exciting discoveries is inevitable.
12th Jenner Glycobiology and Medicine Symposium meeting will provide an international forum for scientists and clinicians to disseminate the findings of current leading edge research in both novel and classic fields of glycobiology and glycomedicine. The conference venue will be the brand new Sheraton Dubrovnik Riviera Hotel just a few min drive from the old city of Dubrovnik. In addition to renowned invited speakers a number of talks will be selected from the submitted abstracts. I hope you will be able to join us in Dubrovnik and help make this conference both enlightening and pleasurable.
Glycan biosynthesis and processing
Glycan analysis
Glycosylation and the immune system
Glycans in angiogenesis and cancer
Glycomics and genomics
Glycans in cell signaling
Glycans and ageing
Glycans: From diagnosis to therapy
Guidelines:
Abstract should be written in English
The abstract should not exceed 2000 characters
Indicate the topic and type of your presentation
Abstract should include the title, names of all contributors (without titles), department, institution, city and country.
Names of author and co-authors have to be submitted in the following way: First and Last name (example: John Smith)
Contact author (presenter) should submit his/her phone and Email address
05月06日
2017
05月09日
2017
摘要截稿日期
注册截止日期
留言